Indications and uses
temporarily relieves minor aches and pains due to: minor pain of arthritis muscular aches backache menstrual cramps headache toothache the common cold temporarily reduces fever
temporarily relieves minor aches and pains due to: minor pain of arthritis muscular aches backache menstrual cramps headache toothache the common cold temporarily reduces fever
do not take more than directed the smallest effective dose should be used drink a full glass of water with each dose if taken with food, this product may take longer to work adults and children 12 years and older: take 1 capsule every 8 to 12 hours while symptoms last for the first dose you may take 2 capsules within the first hour do not exceed 2 capsules in any 8- to 12-hour period do not exceed 3 capsules in a ...
each capsule contains: sodium 20 mg store at 20-25°C (68-77°F). Avoid high humidity and excessive heat above 40°C (104°F). Protect from light. read all directions and warnings before use. Keep carton.
Drug Facts
Pain reliever/fever reducer
Naproxen sodium may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:
NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.
If pregnant or breast-feeding,ask a health professional before use. It is especially important not to use naproxen sodium at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 12 years and older: |
|
| children under 12 years: |
|
FD&C blue #1, gelatin, glycerin, lactic acid, mannitol, pharmaceutical ink, polyethylene glycol, povidone, propylene glycol, purified water, sorbitan, sorbitol
1-888-235-2466 (Mon – Fri 9AM – 5PM EST)
Do not use if printed safety seal under cap is torn or missing.
***This product is not manufactured or distributed by the owners of ALEVE ®Liquid Gels.
PROUDLY DISTRIBUTED BY:
ASSOCIATED WHOLESALE GROCERS, INC., KANSAS CITY, KANSAS 66106
For product information please visit: bestchoicebrand.com/66726
BEST CHOICE
66726 0923 BP
L0000716
R0523
*Compare to the
active ingredient of
ALEVE ®
Liquid Gels
Naproxen
Sodium
CAPSULES 220 mg (NSAID)
PAIN RELIEVER
FEVER REDUCER
Strength to last 12 hours
50
CAPSULES
| Class | Version | Type | Effective |
|---|---|---|---|
| NAPROXEN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fef6ad89-235f-4274-ba49-a8e53642473e | Product name | 2 | 20250225 |
| 87fed3e6-8fba-48ef-96b0-3a7fb54b96ff | Product name | 3 | 20230306 |
| f52be47f-7aa7-46c0-b1fa-50c18dd50206 | Product name | 1 | 20201029 |
| b5fdaaec-7251-4da6-9cb2-4e9e76939ec8 | Product name | 1 | 20200623 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| e76dbbc1-775d-722c-08ff-ed45e8a80def | Product name | 3 | 20181002 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| 597b1cfd-7b31-5048-62be-ca5cd740da2f | Product name | 1 | 20140508 |
| 6f4f4521-fd56-1ae6-888b-3b021bd75c7c | Product name | 1 | 20140508 |
| ce67e27d-1d21-5465-4409-b0662dd99d4d | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63941-681-16 | Naproxen Sodium | 50 in 1 BOTTLE, PLASTIC | CAPSULE, LIQUID FILLED | 50 | 2 | |
| 63941-681-16 | Naproxen Sodium | 1 in 1 CARTON | CAPSULE, LIQUID FILLED | 1 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63941-681 | 63941-681-16 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| FD&C BLUE NO. 1 | H3R47K3TBD | IACT |
| GELATIN | 2G86QN327L | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| LACTIC ACID | 33X04XA5AT | IACT |
| MANNITOL | 3OWL53L36A | IACT |
| POLYETHYLENE GLYCOL, UNSPECIFIED | 3WJQ0SDW1A | IACT |
| POVIDONE K30 | U725QWY32X | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| WATER | 059QF0KO0R | IACT |
| SORBITAN | 6O92ICV9RU | IACT |
| SORBITOL | 506T60A25R | IACT |
| NAPROXEN SODIUM | 9TN87S3A3C | ACTIB |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021920-001 | NAPROXEN SODIUM | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 |
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N021920-001 | 10022344 | 2026-03-03 | U-1731 | Drug product | 2018-07-23 |
| N021920-001 | 10022344 | 2026-03-03 | U-1732 | Drug product | 2018-07-23 |
| N021920-001 | 10028925 | 2026-03-03 | U-1731 | Drug product | 2018-07-24 |
| N021920-001 | 10028925 | 2026-03-03 | U-1732 | Drug product | 2018-07-24 |
| N021920-001 | 11090280 | 2026-03-03 | U-1731 | Drug product | 2021-08-24 |
| N021920-001 | 11090280 | 2026-03-03 | U-1732 | Drug product | 2021-08-24 |
| N021920-001 | 9693978 | 2026-03-03 | Drug product | 2017-11-13 | |
| N021920-001 | 9693979 | 2026-03-03 | Drug product | 2017-11-13 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N021920-001 | NAPROXEN SODIUM | EQ 200MG BASE | CAPSULE / ORAL | RLD, RS | 2006-02-17 | cb3db0bc1861… |
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021920-001 | 10022344 | 2026-03-03 | U-1731 | Drug product | 2018-07-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021920-001 | 10022344 | 2026-03-03 | U-1732 | Drug product | 2018-07-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021920-001 | 10028925 | 2026-03-03 | U-1731 | Drug product | 2018-07-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021920-001 | 10028925 | 2026-03-03 | U-1732 | Drug product | 2018-07-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021920-001 | 11090280 | 2026-03-03 | U-1731 | Drug product | 2021-08-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021920-001 | 11090280 | 2026-03-03 | U-1732 | Drug product | 2021-08-24 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021920-001 | 9693978 | 2026-03-03 | Drug product | 2017-11-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021920-001 | 9693979 | 2026-03-03 | Drug product | 2017-11-13 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021920-001 | 10022344 | 2026-03-03 | U-1731 | Drug product | 2018-07-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021920-001 | 10022344 | 2026-03-03 | U-1732 | Drug product | 2018-07-23 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021920-001 | 10028925 | 2026-03-03 | U-1731 | Drug product | 2018-07-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021920-001 | 10028925 | 2026-03-03 | U-1732 | Drug product | 2018-07-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021920-001 | 11090280 | 2026-03-03 | U-1731 | Drug product | 2021-08-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021920-001 | 11090280 | 2026-03-03 | U-1732 | Drug product | 2021-08-24 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021920-001 | 9693978 | 2026-03-03 | Drug product | 2017-11-13 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021920-001 | 9693979 | 2026-03-03 | Drug product | 2017-11-13 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021920-001 | 10022344 | 2026-03-03 | U-1731 | Drug product | 2018-07-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021920-001 | 10022344 | 2026-03-03 | U-1732 | Drug product | 2018-07-23 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021920-001 | 10028925 | 2026-03-03 | U-1731 | Drug product | 2018-07-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021920-001 | 10028925 | 2026-03-03 | U-1732 | Drug product | 2018-07-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021920-001 | 11090280 | 2026-03-03 | U-1731 | Drug product | 2021-08-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021920-001 | 11090280 | 2026-03-03 | U-1732 | Drug product | 2021-08-24 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021920-001 | 9693978 | 2026-03-03 | Drug product | 2017-11-13 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021920-001 | 9693979 | 2026-03-03 | Drug product | 2017-11-13 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021920-001 | 10022344 | 2026-03-03 | U-1731 | Drug product | 2018-07-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021920-001 | 10022344 | 2026-03-03 | U-1732 | Drug product | 2018-07-23 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021920-001 | 10028925 | 2026-03-03 | U-1731 | Drug product | 2018-07-24 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021920-001 | 10028925 | 2026-03-03 | U-1732 | Drug product | 2018-07-24 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021920-001 | 11090280 | 2026-03-03 | U-1731 | Drug product | 2021-08-24 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021920-001 | 11090280 | 2026-03-03 | U-1732 | Drug product | 2021-08-24 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021920-001 | 9693978 | 2026-03-03 | Drug product | 2017-11-13 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021920-001 | 9693979 | 2026-03-03 | Drug product | 2017-11-13 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021920-001 | 10022344 | 2026-03-03 | U-1731 | Drug product | 2018-07-23 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021920-001 | 10022344 | 2026-03-03 | U-1732 | Drug product | 2018-07-23 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021920-001 | 10028925 | 2026-03-03 | U-1731 | Drug product | 2018-07-24 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021920-001 | 10028925 | 2026-03-03 | U-1732 | Drug product | 2018-07-24 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021920-001 | 11090280 | 2026-03-03 | U-1731 | Drug product | 2021-08-24 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021920-001 | 11090280 | 2026-03-03 | U-1732 | Drug product | 2021-08-24 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021920-001 | 9693978 | 2026-03-03 | Drug product | 2017-11-13 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021920-001 | 9693979 | 2026-03-03 | Drug product | 2017-11-13 | b8a1b40f171c… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen Sodium | NAPROXEN SODIUM | VALU MERCHANDISERS COMPANY | fed305f1-e32d-e1ff-e053-6294a90a273d | 2023-10-03 | Warnings | 63941-681-16 63941-681 63941068116 06d2daf1-3067-95e9-e063-6294a90aa789 fed305f1-e32d-e1ff-e053-6294a90a273d |